The EWS system is designed to aggregate information from multiple vital signs and clinical observations to determine the potential degree of patient deterioration, the Irvine, Calif.-based company said.
“Root, from its versatile connectivity options to its advanced patient monitoring, from rainbow SpHb to SET SpO2, helps hospitals improve patient care. We hope the addition of Early Warning Score to Root will help automate a potentially valuable calculation and streamline its inclusion in EMRs,” founder & CEO Joe Kiani said in a press release.
Masimo said that any time a clinician transfers data to a patients’ electronic medical records via the Root system, connected to the company’s Patient SafetyNet, an EWS can now be included in the data. EWS calculations can also be performed on standalone Root units, the company said.
Earlier this month, Masimo saw shares fall nearly 15% despite the medical device maker beating expectations on Wall Street with its 1st quarter results.
The company posted profits of $45.3 million, or 82¢ per share, on sales of $186.3 million for the 3 months ended April 1, for bottom-line growth of 64.4% on sales growth of 8.8% compared with the same period in the previous year.
Masimo’s earnings per share were solidly ahead of the 54¢ consensus on Wall Street, where analysts were looking for sales of $183.6 million.